Starting Point

A digital health company delivered excellent outcomes, but healthcare systems viewed it as a wellness app.
 

Enterprise deals stalled.

Underlying Structural Problem

The company lacked clinical authority architecture:

• didn’t map to reimbursement pathways

• no clinical-grade terminology or validation flow

• misaligned product positioning

• investors saw high churn/low defensibility risk
   

Strategic Interventions

In 9 days, we rebuilt clinical identity:

• repositioned as clinical decision-support infrastructure

• mapped product to reimbursable CPT codes

• reframed outcomes around reductions in cost-of-care

• built evidence pathways aligned with insurers and health systems
   

Impact

• enterprise deal velocity increased 3×

• qualified for two reimbursement pathways

• valuation uplift: +$16M

• investor categorisation upgraded from “digital health” to “clinical infrastructure”